口蹄疫疫苗质量:基于VP4检测完整病毒衣壳的通用试验
本研究鉴定并表征了新型单克隆抗体5B6,可经VP4衣壳蛋白N端附近保守表位检测所有血清型口蹄疫病毒,识别含VP4的完整146S保护性抗原而不识别缺乏VP4的12S解离衣壳,据此开发了简便ELISA通用试验,可用于评估配制后疫苗或未配制疫苗抗原的质量。
要点
- 单克隆抗体5B6经VP4保守表位可检测所有血清型口蹄疫病毒。
- 该抗体识别完整146S保护性抗原,不识别缺乏VP4的12S解离衣壳。
- 基于该抗体开发了简便ELISA通用试验,可检测疫苗样品中的保护性抗原。
核心结论
- 基于单克隆抗体5B6的ELISA通用试验可特异性检测疫苗样品中的完整146S保护性抗原,有助于提升口蹄疫疫苗接种规划的效果。
研究设计与样本
- 本研究鉴定并表征了新型单克隆抗体5B6,并基于该抗体开发了检测口蹄疫疫苗中完整病毒衣壳的ELISA通用试验。
主要发现
- 单克隆抗体5B6通过VP4衣壳蛋白N端附近的保守表位检测所有血清型口蹄疫病毒。
- 该抗体识别含VP4的完整146S保护性抗原,不识别缺乏VP4的12S解离衣壳。
临床怎么用
- 该试验可用于评估生产后配制疫苗或给药前疫苗的质量,也可用于评估未配制的疫苗抗原。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Foot-and-mouth disease virus (FMDV) causes an economically devastating disease of livestock that is controlled in endemic areas by vaccines containing intact inactivated FMDV particles. In this study, a novel monoclonal antibody named 5B6 has been identified and characterised, that permits the detection of all serotypes of FMDV via a conserved epitope near the N-terminus of the VP4 capsid protein. The antibody recognises intact virus particles known as 146S (the protective antigen) which contain VP4 and not dissociated capsids known as 12S (poorly protective antigen) which lack VP4. This allowed the development of a universal assay to specifically detect the protective antigen in vaccine samples using a simple ELISA. Such a test could be used to assess the quality of formulated vaccine following manufacture or prior to administration, or to assess unformulated vaccine antigen, and would be of great utility to enhance the effectiveness of FMD vaccination programmes.
引用
- Berryman S, Asfor A, Benham E, et al. Foot-and-mouth disease vaccine quality: A universal test for intact viral capsids based on detection of VP4. Vaccine. 2025. PMID: 39952120. doi:10.1016/j.vaccine.2025.126845
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。